A detailed history of Virtus ETF Advisers LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,268 shares of MRNA stock, worth $83,575. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,268
Previous 2,268 -0.0%
Holding current value
$83,575
Previous $269,000 43.87%
% of portfolio
0.07%
Previous 0.14%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $219,524 - $361,377
-2,169 Reduced 48.88%
2,268 $269,000
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $54,466 - $73,650
638 Added 16.79%
4,437 $472,000
Q4 2023

Feb 15, 2024

BUY
$69.51 - $104.43 $96,271 - $144,635
1,385 Added 57.37%
3,799 $377,000
Q3 2023

Nov 07, 2023

SELL
$96.41 - $126.61 $558,695 - $733,704
-5,795 Reduced 70.59%
2,414 $249,000
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $798,334 - $1.08 Million
6,737 Added 457.68%
8,209 $997,000
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $3,255 - $4,728
24 Added 1.66%
1,472 $226,000
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $58,242 - $103,339
-492 Reduced 25.36%
1,448 $260,000
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $610,776 - $1 Million
-5,173 Reduced 72.73%
1,940 $229,000
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $675,957 - $1.02 Million
5,771 Added 430.03%
7,113 $1.02 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $195,560 - $319,129
-866 Reduced 39.22%
1,342 $341,000
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $44,158 - $96,409
-199 Reduced 8.27%
2,208 $850,000
Q2 2021

Aug 10, 2021

SELL
$129.91 - $234.98 $210,973 - $381,607
-1,624 Reduced 40.29%
2,407 $566,000
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $11,573 - $19,713
106 Added 2.7%
4,031 $528,000
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $68,961 - $178,183
-1,049 Reduced 21.09%
3,925 $410,000
Q3 2020

Nov 13, 2020

SELL
$54.34 - $94.85 $37,277 - $65,067
-686 Reduced 12.12%
4,974 $352,000
Q2 2020

Aug 05, 2020

SELL
$29.67 - $80.0 $404,817 - $1.09 Million
-13,644 Reduced 70.68%
5,660 $363,000
Q1 2020

May 14, 2020

SELL
$17.78 - $31.58 $50,299 - $89,339
-2,829 Reduced 12.78%
19,304 $578,000
Q4 2019

Feb 13, 2020

BUY
$13.93 - $21.28 $79,902 - $122,062
5,736 Added 34.98%
22,133 $433,000
Q3 2019

Nov 12, 2019

SELL
$12.26 - $18.07 $11,205 - $16,515
-914 Reduced 5.28%
16,397 $261,000
Q2 2019

Aug 13, 2019

BUY
$13.7 - $28.34 $237,160 - $490,593
17,311 New
17,311 $253,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.